Meeting
2020 Gastrointestinal Cancers Symposium
Changes in glucose tolerance after pancreatectomy in patients with pancreatic ductal adenocarcinoma.
Authors
Sachiyo Shirakawa
Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan
Sachiyo Shirakawa , Hirochika Toyama , Shohei Komatsu , Jun Ishida , Masahiro Kido , Takumi Fukumoto
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Hepatobiliary Cancer, Neuroendocrine/Carcinoid, Pancreatic Cancer, and Small Bowel Cancer
Track
Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Pancreatic Cancer,Small Bowel Cancer,Other GI Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr 668)
Abstract #
668
Poster Bd #
H21
Abstract Disclosures
Similar Posters
Poster
2016 Gastrointestinal Cancers Symposium
Effect of metformin on survival in pancreatic ductal adenocarcinoma.
First Author: Sunil Amin
Poster
2024 ASCO Annual Meeting
Uncontrolled diabetes mellitus and the progression of monoclonal gammopathy of undetermined significance to multiple myeloma in US veterans.
First Author: Lawrence Liu
Poster
2022 ASCO Annual Meeting
Immune checkpoint inhibitor–induced diabetes mellitus across NCI trials.
First Author: Zoe E. Quandt
Poster
2022 ASCO Genitourinary Cancers Symposium
Does presence of diabetes mellitus impact patient oncological outcomes in renal cell carcinoma: A multicenter analysis.
First Author: Ava Saidian